Lexicon Pharmaceuticals, Inc. - stock earnings
LXRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -48.2 million USD | 702000 USD |
| 2023Q3 | -50.5 million USD | 162000 USD |
| 2023Q2 | -44.9 million USD | 317000 USD |
| 2023Q1 | -30.9 million USD | 24000 USD |
| 2022Q4 | -30.7 million USD | 28000 USD |
| 2022Q3 | -23.7 million USD | 39000 USD |
| 2022Q2 | -25.2 million USD | 35000 USD |
| 2022Q1 | -23.6 million USD | 37000 USD |
| 2021Q4 | -25.6 million USD | 14000 USD |
| 2021Q3 | -23.1 million USD | 23000 USD |
| 2021Q2 | -18.1 million USD | 234000 USD |
| 2021Q1 | -21.0 million USD | 27000 USD |
| 2020Q4 | -5.5 million USD | 199000 USD |
| 2020Q3 | 82.6 million USD | 6.6 million USD |
| 2020Q2 | -69.1 million USD | 9.2 million USD |
| 2020Q1 | -66.6 million USD | 8.0 million USD |
| 2019Q4 | -51.1 million USD | 8.7 million USD |
| 2019Q3 | 226.1 million USD | 294.4 million USD |
| 2019Q2 | -23.0 million USD | 9.7 million USD |
| 2019Q1 | -21.8 million USD | 9.2 million USD |
| 2018Q4 | -16.8 million USD | 17.1 million USD |
| 2018Q3 | -27.5 million USD | 6.9 million USD |
| 2018Q2 | -34.7 million USD | 13.8 million USD |
| 2018Q1 | -42.1 million USD | 25.2 million USD |
| 2017Q4 | -28.4 million USD | 33.0 million USD |
| 2017Q3 | -30.7 million USD | 26.9 million USD |
| 2017Q2 | -35.1 million USD | 12.1 million USD |
| 2017Q1 | -34.9 million USD | 18.3 million USD |
| 2016Q4 | -32.4 million USD | 23.0 million USD |
| 2016Q3 | -36.0 million USD | 27.7 million USD |
| 2016Q2 | -38.1 million USD | 20.1 million USD |
| 2016Q1 | -34.9 million USD | 12.5 million USD |
| 2015Q4 | 86.8 million USD | 127.3 million USD |
| 2015Q3 | -35.3 million USD | 566000 USD |
| 2015Q2 | -28.1 million USD | 376000 USD |
| 2015Q1 | -28.1 million USD | 1.8 million USD |
| 2014Q4 | -2.9 million USD | 21.5 million USD |
| 2014Q3 | -40.5 million USD | 419000 USD |
| 2014Q2 | -26.0 million USD | 676000 USD |
| 2014Q1 | -30.8 million USD | 277000 USD |
| 2013Q4 | -17.4 million USD | 1.4 million USD |
| 2013Q3 | -31.7 million USD | 238000 USD |
| 2013Q2 | -29.1 million USD | 214000 USD |
| 2013Q1 | -26.0 million USD | 360000 USD |
| 2012Q4 | -24.9 million USD | 218000 USD |
| 2012Q3 | -29.5 million USD | 372000 USD |
| 2012Q2 | -25.9 million USD | 199000 USD |
| 2012Q1 | -29.9 million USD | 300000 USD |
| 2011Q4 | -33.8 million USD | 343000 USD |
| 2011Q3 | -26.1 million USD | 355000 USD |
| 2011Q2 | -26.6 million USD | 555000 USD |
| 2011Q1 | -29.6 million USD | 596000 USD |
| 2010Q4 | -23.0 million USD | 1.3 million USD |
| 2010Q3 | -27.5 million USD | 781000 USD |
| 2010Q2 | -25.2 million USD | 1.2 million USD |
| 2010Q1 | -26.1 million USD | 1.6 million USD |
| 2009Q4 | -22.0 million USD | 1.4 million USD |
| 2009Q3 | -19.1 million USD | 2.1 million USD |
| 2009Q2 | -23.5 million USD | 3.0 million USD |
| 2009Q1 | -21.6 million USD | 4.2 million USD |
| 2008Q4 | -15.4 million USD | 6.4 million USD |
| 2008Q3 | -23.5 million USD | 7.5 million USD |
| 2008Q2 | -20.0 million USD | 9.6 million USD |
| 2008Q1 | -22.9 million USD | 8.9 million USD |
| 2007Q4 | -12.2 million USD | 13.8 million USD |
| 2007Q3 | -14.1 million USD | 10.2 million USD |
| 2007Q2 | -13.6 million USD | 12.6 million USD |
| 2007Q1 | -18.9 million USD | 13.5 million USD |
| 2006Q4 | -13.8 million USD | 16.1 million USD |
| 2006Q3 | -12.8 million USD | 19.6 million USD |
| 2006Q2 | -16.9 million USD | 16.2 million USD |
| 2006Q1 | -10.8 million USD | 21.0 million USD |
| 2005Q4 | 5.9 million USD | 33.9 million USD |
| 2005Q3 | -14.1 million USD | 14.0 million USD |
| 2005Q2 | -14.8 million USD | 13.9 million USD |
| 2005Q1 | -13.3 million USD | 13.9 million USD |
| 2004Q4 | -541000 USD | 26.0 million USD |
| 2004Q3 | -14.4 million USD | 13.1 million USD |
| 2004Q2 | -16.8 million USD | 10.8 million USD |
| 2004Q1 | -15.5 million USD | 11.8 million USD |
| 2003Q4 | -14.9 million USD | 13.7 million USD |
| 2003Q3 | -14.6 million USD | 12.1 million USD |
| 2003Q2 | -17.6 million USD | 8.9 million USD |
| 2003Q1 | -17.1 million USD | 8.1 million USD |
| 2002Q4 | -13.9 million USD | 10.1 million USD |
| 2002Q3 | -16.8 million USD | 8.0 million USD |
| 2002Q2 | -14.9 million USD | 9.4 million USD |
| 2002Q1 | -14.1 million USD | 7.7 million USD |
| 2001Q4 | -11.0 million USD | 285.3 million USD |
| 2001Q3 | -6.2 million USD | 13.5 million USD |
| 2001Q2 | -9.9 million USD | 3.5 million USD |
| 2001Q1 | -8.0 million USD | 3.3 million USD |
| 2000Q4 | -7.5 million USD | 2.9 million USD |
| 2000Q3 | -1.5 million USD | 5.6 million USD |
| 2000Q2 | -3.5 million USD | 2.6 million USD |
| 2000Q1 | -13.4 million USD | 3.3 million USD |
LXRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -175.6 million USD | 1.2 million USD |
| 2022 | -103.1 million USD | 139000 USD |
| 2021 | -88.3 million USD | 298000 USD |
| 2020 | -70.2 million USD | 24.0 million USD |
| 2019 | 130.1 million USD | 322.1 million USD |
| 2018 | -120.5 million USD | 63.2 million USD |
| 2017 | -129.1 million USD | 90.3 million USD |
| 2016 | -141.4 million USD | 83.3 million USD |
| 2015 | -4.7 million USD | 130.0 million USD |
| 2014 | -100.3 million USD | 22.9 million USD |
| 2013 | -104.1 million USD | 2.2 million USD |
| 2012 | -110.2 million USD | 1.1 million USD |
| 2011 | -116.2 million USD | 1.8 million USD |
| 2010 | -101.8 million USD | 4.9 million USD |
| 2009 | -82.8 million USD | 10.7 million USD |
| 2008 | -76.9 million USD | 32.3 million USD |
| 2007 | -58.8 million USD | 50.1 million USD |
| 2006 | -54.3 million USD | 72.8 million USD |
| 2005 | -36.3 million USD | 75.7 million USD |
| 2004 | -47.2 million USD | 61.7 million USD |
| 2003 | -64.2 million USD | 42.8 million USD |
| 2002 | -59.7 million USD | 35.2 million USD |
| 2001 | -35.2 million USD | 305.6 million USD |
| 2000 | -26.0 million USD | 14.5 million USD |
| 1999 | -12.5 million USD | 4.7 million USD |
LXRX
Price: $1.56
52 week price:
Earnings Per Share: -0.80 USD
P/E Ratio: -4.38
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 131023
Ebitda: -28.2 millionMarket Capitalization: 460.5 million